Evidence & regulatory context
- Mechanism
- No confident ChEMBL match; neurotensin receptor agonist (research)
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatTBIControlled cortical impactWistarn = 5 to 8 per group for contusion volume quantificationIntraperitonealFirst bolus 2 mg/kg then one or two further injections at 1…First bolus 15 min after injury; delayed paradigms started at 1 h or 2 h after…
Model: Controlled cortical impact through a 3.5 mm craniotomy 2.0 mm right of the central suture, 3.0 mm flat tip, velocity 3 m/s, depth 2.0 mm, contact time 150 ms
A single bolus produced a dose-dependent 2 to 5 degree fall in body and brain temperature, and the 2 mg/kg plus 1 mg/kg regimen maintained mild hypothermia for at least 6 h without shivering. Treated pups had smaller contusion volumes, fewer TUNEL-positive and TUNEL/NeuN cells, reduced caspase-3 wi…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.